Heather Getz Acquires 20,000 Shares of Myomo (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Heather Getz acquired 20,000 shares of the company’s stock in a transaction on Monday, March 16th. The shares were acquired at an average cost of $0.70 per share, for a total transaction of $14,000.00. Following the completion of the acquisition, the director owned 131,754 shares of the company’s stock, valued at approximately $92,227.80. The trade was a 17.90% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Myomo Price Performance

Shares of NYSEAMERICAN:MYO opened at $0.72 on Thursday. The firm has a market capitalization of $27.92 million, a PE ratio of -1.96 and a beta of 1.17. The company has a quick ratio of 2.93, a current ratio of 3.30 and a debt-to-equity ratio of 0.98. The company has a 50-day moving average price of $0.83 and a two-hundred day moving average price of $0.91. Myomo, Inc. has a twelve month low of $0.63 and a twelve month high of $5.62.

Analyst Upgrades and Downgrades

Several research analysts recently commented on MYO shares. Ascendiant Capital Markets cut their price objective on shares of Myomo from $10.50 to $10.00 and set a “buy” rating for the company in a report on Friday, November 21st. Craig Hallum reissued a “buy” rating on shares of Myomo in a report on Tuesday, March 10th. Four equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $7.67.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Rosalind Advisors Inc. increased its position in shares of Myomo by 1.3% during the fourth quarter. Rosalind Advisors Inc. now owns 3,839,772 shares of the company’s stock valued at $3,494,000 after buying an additional 48,984 shares during the period. Jefferies Financial Group Inc. purchased a new stake in shares of Myomo in the fourth quarter worth about $641,000. Geode Capital Management LLC boosted its position in shares of Myomo by 160.8% in the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock valued at $1,446,000 after acquiring an additional 412,631 shares during the period. Stonepine Capital Management LLC boosted its position in shares of Myomo by 65.3% in the second quarter. Stonepine Capital Management LLC now owns 457,419 shares of the company’s stock valued at $988,000 after acquiring an additional 180,712 shares during the period. Finally, AQR Capital Management LLC grew its stake in Myomo by 47.8% during the fourth quarter. AQR Capital Management LLC now owns 434,376 shares of the company’s stock valued at $395,000 after acquiring an additional 140,427 shares in the last quarter. Hedge funds and other institutional investors own 44.99% of the company’s stock.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.